The gastrin-releasing peptide receptor (GRPR), now properly known as BB2 [5] is a G protein-coupled receptor whose endogenous ligand is gastrin releasing peptide.[6] In humans it is highly expressed in the pancreas and is also expressed in the stomach, adrenal cortex and brain.[7]
Gastrin-releasing peptide (GRP) regulates numerous functions of the gastrointestinal and central nervous systems, including release of gastrointestinal hormones, smooth muscle cell contraction, and epithelial cell proliferation and is a potent mitogen for neoplastic tissues. The effects of GRP are mediated through the gastrin-releasing peptide receptor. This receptor is a glycosylated, 7-transmembrane G-protein coupled receptor that activates the phospholipase C signaling pathway. The receptor is aberrantly expressed in numerous cancers such as those of the lung, colon, and prostate. An individual with autism and multiple exostoses was found to have a balanced translocation between chromosome 8 and an X chromosome breakpoint located within the gastrin-releasing peptide receptor gene.[8][9]
The transcription factor CREB is a regulator of human GRP-R expression in colon cancer.[10]
Activation MOR1D‐GRPR heteromers in the spinal cord mediate the common troublesome opioid-induced itch.
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000126010 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000031364 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Bombesin Receptors: BB2". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
- ^ Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT (January 1995). "Expression and characterization of cloned human bombesin receptors". Molecular Pharmacology. 47 (1): 10–20. doi:10.1016/S0026-895X(25)08508-6. PMID 7838118. Archived from the original on 2008-09-06. Retrieved 2007-08-23.
- ^ Corjay MH, Dobrzanski DJ, Way JM, Viallet J, Shapira H, Worland P, et al. (October 1991). "Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells". The Journal of Biological Chemistry. 266 (28): 18771–18779. doi:10.1016/S0021-9258(18)55129-2. PMID 1655761.
- ^ "Entrez Gene: GRPR gastrin-releasing peptide receptor".
- ^ Ishikawa-Brush Y, Powell JF, Bolton P, Miller AP, Francis F, Willard HF, et al. (August 1997). "Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene". Human Molecular Genetics. 6 (8): 1241–1250. doi:10.1093/hmg/6.8.1241. PMID 9259269.
- ^ Chinnappan D, Qu X, Xiao D, Ratnasari A, Weber HC (July 2008). "Human gastrin-releasing peptide receptor gene regulation requires transcription factor binding at two distinct CRE sites". American Journal of Physiology. Gastrointestinal and Liver Physiology. 295 (1): G153 – G162. doi:10.1152/ajpgi.00036.2008. PMC 2494719. PMID 18483184.
Further reading
- Corjay MH, Dobrzanski DJ, Way JM, Viallet J, Shapira H, Worland P, et al. (October 1991). "Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells". The Journal of Biological Chemistry. 266 (28): 18771–18779. doi:10.1016/S0021-9258(18)55129-2. PMID 1655761.
- Alitalo T, Francis F, Kere J, Lehrach H, Schlessinger D, Willard HF (February 1995). "A 6-Mb YAC contig in Xp22.1-p22.2 spanning the DXS69E, XE59, GLRA2, PIGA, GRPR, CALB3, and PHKA2 genes". Genomics. 25 (3): 691–700. doi:10.1016/0888-7543(95)80012-B. PMID 7759104.
- Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT (January 1995). "Expression and characterization of cloned human bombesin receptors". Molecular Pharmacology. 47 (1): 10–20. doi:10.1016/S0026-895X(25)08508-6. PMID 7838118.
- Giladi E, Nagalla SR, Spindel ER (1993). "Molecular cloning and characterization of receptors for the mammalian bombesin-like peptides". Journal of Molecular Neuroscience. 4 (1): 41–54. doi:10.1007/BF02736689. PMID 8391296. S2CID 20854144.
- Maslen GL, Boyd Y (July 1993). "Comparative mapping of the Grpr locus on the X chromosomes of man and mouse". Genomics. 17 (1): 106–109. doi:10.1006/geno.1993.1290. PMID 8406441.
- Ishikawa-Brush Y, Powell JF, Bolton P, Miller AP, Francis F, Willard HF, et al. (August 1997). "Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene". Human Molecular Genetics. 6 (8): 1241–1250. doi:10.1093/hmg/6.8.1241. PMID 9259269.
- Heidary G, Hampton LL, Schanen NC, Rivkin MJ, Darras BT, Battey J, Francke U (June 1998). "Exclusion of the gastrin-releasing peptide receptor (GRPR) locus as a candidate gene for Rett syndrome". American Journal of Medical Genetics. 78 (2): 173–175. doi:10.1002/(SICI)1096-8628(19980630)78:2<173::AID-AJMG15>3.0.CO;2-K. PMID 9674911.
- Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Davis AL, Luketich JD, Siegfried JM (January 2000). "Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer". Journal of the National Cancer Institute. 92 (1): 24–33. doi:10.1093/jnci/92.1.24. PMID 10620630.
- Xiao D, Wang J, Hampton LL, Weber HC (February 2001). "The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter". Gene. 264 (1): 95–103. doi:10.1016/S0378-1119(00)00596-5. PMID 11245983.
- Carroll RE, Matkowskyj K, Saunthararajah Y, Sekosan M, Battey JF, Benya RV (May 2002). "Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract". Mechanisms of Development. 113 (2): 121–130. doi:10.1016/S0925-4773(02)00032-1. PMID 11960700. S2CID 15515339.
- Qu X, Xiao D, Weber HC (September 2002). "Human gastrin-releasing peptide receptor mediates sustained CREB phosphorylation and transactivation in HuTu 80 duodenal cancer cells". FEBS Letters. 527 (1–3): 109–113. Bibcode:2002FEBSL.527..109Q. doi:10.1016/S0014-5793(02)03177-0. PMID 12220644. S2CID 26497603.
- Xiao D, Qu X, Weber HC (November 2002). "GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells". Regulatory Peptides. 109 (1–3): 141–148. doi:10.1016/S0167-0115(02)00197-0. PMID 12409226. S2CID 20563506.
- Uchida K, Kojima A, Morokawa N, Tanabe O, Anzai C, Kawakami M, et al. (December 2002). "Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer". Journal of Cancer Research and Clinical Oncology. 128 (12): 633–640. doi:10.1007/s00432-002-0392-8. PMC 12164429. PMID 12474049. S2CID 23764903.
- Shumyatsky GP, Tsvetkov E, Malleret G, Vronskaya S, Hatton M, Hampton L, et al. (December 2002). "Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear". Cell. 111 (6): 905–918. doi:10.1016/S0092-8674(02)01116-9. PMID 12526815. S2CID 16950847.
- Glover SC, Tretiakova MS, Carroll RE, Benya RV (May 2003). "Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression". Molecular Carcinogenesis. 37 (1): 5–15. doi:10.1002/mc.10117. PMID 12720295. S2CID 35607051.
- Waters CM, MacKinnon AC, Cummings J, Tufail-Hanif U, Jodrell D, Haslett C, Sethi T (June 2003). "Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition". British Journal of Cancer. 88 (11): 1808–1816. doi:10.1038/sj.bjc.6600957. PMC 2377129. PMID 12771999.
- Scott N, Millward E, Cartwright EJ, Preston SR, Coletta PL (February 2004). "Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours". Journal of Clinical Pathology. 57 (2): 189–192. doi:10.1136/jcp.2003.10660. PMC 1770197. PMID 14747448.
- Chen PW, Kroog GS (December 2004). "Alterations in receptor expression or agonist concentration change the pathways gastrin-releasing peptide receptor uses to regulate extracellular signal-regulated kinase". Molecular Pharmacology. 66 (6): 1625–1634. doi:10.1124/mol.104.001206. PMID 15361544. S2CID 31811739.
External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.